JP2012500786A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500786A5
JP2012500786A5 JP2011523446A JP2011523446A JP2012500786A5 JP 2012500786 A5 JP2012500786 A5 JP 2012500786A5 JP 2011523446 A JP2011523446 A JP 2011523446A JP 2011523446 A JP2011523446 A JP 2011523446A JP 2012500786 A5 JP2012500786 A5 JP 2012500786A5
Authority
JP
Japan
Prior art keywords
composition
flurbiprofen
composition according
amylmetacresol
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011523446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500786A (ja
Filing date
Publication date
Priority claimed from GB0815405A external-priority patent/GB0815405D0/en
Priority claimed from GB0900288A external-priority patent/GB0900288D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/002014 external-priority patent/WO2010020772A2/en
Publication of JP2012500786A publication Critical patent/JP2012500786A/ja
Publication of JP2012500786A5 publication Critical patent/JP2012500786A5/ja
Pending legal-status Critical Current

Links

JP2011523446A 2008-08-22 2009-08-18 組成物における改良又は組成物に関連した改良 Pending JP2012500786A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0815405A GB0815405D0 (en) 2008-08-22 2008-08-22 Novel compositions
GB0815405.6 2008-08-22
GB0900288.2 2009-01-09
GB0900288A GB0900288D0 (en) 2009-01-09 2009-01-09 Novel compositions
PCT/GB2009/002014 WO2010020772A2 (en) 2008-08-22 2009-08-18 Improvements in or relating to compositions

Publications (2)

Publication Number Publication Date
JP2012500786A JP2012500786A (ja) 2012-01-12
JP2012500786A5 true JP2012500786A5 (enExample) 2012-10-04

Family

ID=41343399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011523446A Pending JP2012500786A (ja) 2008-08-22 2009-08-18 組成物における改良又は組成物に関連した改良

Country Status (14)

Country Link
US (2) US8569375B2 (enExample)
EP (1) EP2328549B1 (enExample)
JP (1) JP2012500786A (enExample)
KR (1) KR20110056500A (enExample)
CN (1) CN102131496B (enExample)
AU (1) AU2009284011B2 (enExample)
BR (1) BRPI0917191A2 (enExample)
CA (1) CA2733180A1 (enExample)
MX (1) MX344359B (enExample)
MY (1) MY155652A (enExample)
RU (1) RU2493829C2 (enExample)
TW (1) TW201010744A (enExample)
WO (1) WO2010020772A2 (enExample)
ZA (1) ZA201100960B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
CN102131496B (zh) * 2008-08-22 2013-10-23 雷克特本克斯尔保健(英国)有限公司 组合物的改进或与组合物有关的改进
US20120283668A1 (en) * 2011-05-04 2012-11-08 Pinchas Shalev Apparatus and method for using effervescent tablets for cosmetic care
US20130284637A1 (en) 2012-04-30 2013-10-31 Danisco Us Inc. Unit-dose format perhydrolase systems
KR20150100705A (ko) * 2013-04-18 2015-09-02 더 허쉬 컴퍼니 미분 점활제를 함유하는 식용물질
WO2016126217A1 (en) * 2015-02-03 2016-08-11 Pharmacti̇ve Ilaç Sanayi̇ Ve Ti̇caret A. Ş. Stable pharmaceutical combination containing benzydamine
CA3050738A1 (en) * 2017-02-01 2018-08-09 Johnson & Johnson Consumer Inc. A lozenge
AU2018300075B2 (en) * 2017-07-10 2024-02-29 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
WO2020013781A2 (en) 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
WO2022005932A1 (en) * 2020-06-30 2022-01-06 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Lozenge
RU2741388C1 (ru) * 2020-08-06 2021-01-25 Закрытое акционерное общество "АФОФАРМ" (ЗАО "АФОФАРМ") Лекарственный препарат в форме таблеток для профилактики и/или лечения простудных, острых респираторных и других инфекционно-воспалительных заболеваний горла и полости рта

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6216413A (ja) * 1985-07-12 1987-01-24 Teijin Ltd キチン類誘導体を用いた徐放性医薬品組成物
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
AU4988696A (en) * 1995-03-29 1996-10-16 Procter & Gamble Company, The Antitussive microcapsules
KR100598714B1 (ko) * 1995-12-21 2006-07-10 파마슈티스크 라보라토리움 페링 에이/에스 5-아미노살리실산을 함유하는 방출 제어형 경구용 약제학적조성물 및 장 질환을 치료하는 방법
IT1297233B1 (it) * 1996-10-29 1999-08-09 Montefarmaco Spa Composizioni farmaceutiche solide in forma di caramelle contenenti disinfettanti e sostanze mucoadesive per una disinfezione topica
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
WO2000035418A2 (en) * 1998-12-18 2000-06-22 Bayer Corporation Chewable drug delivery system
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
JP2003002828A (ja) * 2001-04-17 2003-01-08 Tanabe Seiyaku Co Ltd 口腔粘膜等における炎症性疾患の予防・治療剤
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP4754211B2 (ja) * 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
EP2015761A4 (en) * 2006-03-29 2009-07-29 Naveh Pharma 1996 Ltd METHOD AND COMPOSITION FOR THE TREATMENT OF NUTRITIONAL IGNITION
JP2007314529A (ja) * 2006-04-28 2007-12-06 Lion Corp 造粒粒子、錠剤、及び造粒粒子の製造方法
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
CN102131496B (zh) * 2008-08-22 2013-10-23 雷克特本克斯尔保健(英国)有限公司 组合物的改进或与组合物有关的改进

Similar Documents

Publication Publication Date Title
JP2012500786A5 (enExample)
RU2011110715A (ru) Улучшение композиций или того, что имеет отношение к композициям
JP2009536147A5 (enExample)
JP6174744B2 (ja) ロキソプロフェン含有医薬製剤
JP2009541479A5 (enExample)
JP2009543885A5 (enExample)
EP2444072A3 (en) Non-mucoadhesive film dosage forms
JP2010537989A5 (enExample)
WO2011079239A3 (en) Combination tablet with chewable outer layer
JP2012031131A5 (enExample)
JP2012515184A5 (enExample)
Şenel et al. Current status and future of delivery systems for prevention and treatment of infections in the oral cavity
JP2009501801A5 (enExample)
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2015505295A5 (enExample)
CN1735434A (zh) 用于预防和治疗伤风与类流感症状的包含精选粘附聚合物的组合物
JP2009508916A5 (enExample)
JP7523879B2 (ja) 医薬組成物
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
RU2015112586A (ru) Фармацевтические композиции, содержащие флурбипрофен
WO2013031935A1 (ja) 安定な医薬組成物
TH145962A (th) องค์ประกอบพาร์ทิคิวเลทที่กินได้ชนิดใหม่
CN102485216A (zh) 一种药品爽口片
RU2023125283A (ru) Фармацевтические композиции, содержащие флурбипрофен
Choi et al. Multi-layered matrix tablets with various tablet designs and release profiles